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Abstract
TCRep 3D is an automated systematic approach for TCR-peptide-MHC class I structure prediction, based on homology and
ab initio modeling. It has been considerably generalized from former studies to be applicable to large repertoires of TCR.
First, the location of the complementary determining regions of the target sequences are automatically identified by a
sequence alignment strategy against a database of TCR Va and Vb chains. A structure-based alignment ensures automated
identification of CDR3 loops. The CDR are then modeled in the environment of the complex, in an ab initio approach based
on a simulated annealing protocol. During this step, dihedral restraints are applied to drive the CDR1 and CDR2 loops
towards their canonical conformations, described by Al-Lazikani et. al. We developed a new automated algorithm that
determines additional restraints to iteratively converge towards TCR conformations making frequent hydrogen bonds with
the pMHC. We demonstrated that our approach outperforms popular scoring methods (Anolea, Dope and Modeller) in
predicting relevant CDR conformations. Finally, this modeling approach has been successfully applied to experimentally
determined sequences of TCR that recognize the NY-ESO-1 cancer testis antigen. This analysis revealed a mechanism of
selection of TCR through the presence of a single conserved amino acid in all CDR3b sequences. The important structural
modifications predicted in silico and the associated dramatic loss of experimental binding affinity upon mutation of this
amino acid show the good correspondence between the predicted structures and their biological activities. To our
knowledge, this is the first systematic approach that was developed for large TCR repertoire structural modeling.
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Introduction
Recognition by the CD8+ T-cell receptor (TCR) of immuno-
genic peptide (p) presented by class I major histocompatibility
complexes (MHC) is one key event in the specific immune
response against virus-infected cells or tumor cells, leading to T-
cell activation and killing of the target cell. Structural studies have
revealed how the molecular recognition of pMHC by the TCR is
mediated by six complementary determining regions (CDR) of the
TCR at the interface with the pMHC complex. Each chain of the
TCR (a and b) is bearing three loops called CDR1, CDR2 and
CDR3. The CDR2 loops form the outside of the binding site, thus
mainly contacting the alpha helices of the pMHC. CDR2 loops
hence participate in the diagonal binding orientation that is
generally observed on TCRpMHC structures [1]. CDR1 loops
interact with the MHC but also contact the N- and C-termini of
the peptide [2] [3] along with CDR3 that are the central loops in
the TCR binding site and mostly interact with the peptide.
However, the commonly accepted paradigm of CDR1 and CDR2
binding to the MHC and CDR3 to the peptide does not fully
account for the true structural complexity of TCRpMHC
complexes. Indeed, all CDR loops interact both with the peptide
and MHC and their modeling should not favor peptide or MHC
interactions regardless of the CDR studied [4].
CDR3 sequences are encoded by combination of gene elements,
P- and N-region nucleotide addition and joining flexibility
conferring a much greater diversity of lengths and sequences.
The study of Al-Lazikani et al. [5] on existing TCRpMHC
experimental structures revealed the existence of a limited number
of canonical backbone conformations for CDR1 and 2 of both Va
and Vb of the TCR. These canonical groups of CDR1 and CDR2
structures are identified by a combination of CDR length
requirements and the presence of key residues at defined positions
within the TCR sequences.
Experimental techniques used to determine the sequences of
TCR that bind to a pMHC complex [6] have recently been used
intensively, leading to the collection of large repertoires of TCR
sequences that are specific for a given pMHC [7] [2]. In recent
studies on the immunodominant human tumor antigen Melan-
A(MART-1) [2] and on the NY-ESO-1 cancer testis antigen [7],
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HLA-A*0201 pMHC complex. The TCR repertoire specific for
the Melan-A decamer (ELAGIGILTV) was biased towards a
Va2.1 usage and that of NY-ESO-1 (SLLMWITQC) towards
Vb13, Vb1 and Vb8. To understand the selection mechanisms
that underlie these restricted gene usage, there is a need for in silico
approaches that take thorough advantage of the knowledge
accumulated in TCRpMHC biology [8]. Such dedicated system
may provide model structures that convey functional information
and allow the identification of conserved 3D binding motifs that
are not obvious from repertoire sequences alone.
Following the study of Michielin et al. [9], we set up an expert
modeling method, called TCRep 3D, dedicated to the modeling of
high quality TCRpMHC complexes, and focusing on the CDR
loops structure. This approach has been designed to include
optimal automation to analyze numerous TCR sequences and
provide functional insight on the interaction between TCR and
pMHC. It makes use of homology models of TCRpMHC [10] [9],
based on the constantly increasing list of available crystal
structures that have been solved since the first one in 1996 [11]
and are available in the Protein Data Bank [12] (http://www.rcsb.
org/). Importantly, we developed in this study a dedicated method
for systematic ab initio refinement of the six CDR loops using a
simulated annealing approach. This method is based on the fact
that hydrogen bonds between the TCR and the pMHC are known
to be of major importance for the TCRpMHC complexation and
protein-protein interaction [13]. Such potential bonds were
intensively searched during this step of the modeling, by iteratively
generating conformers of a CDR loop, and by including new
restraints derived from the hydrogen bonds statistics of the
previous iterations in the subsequent ones. The canonical loop
information [5] is also accounted for by means of additional
restraints automatically derived by our program. Our approach
does not favor explicitly the CDRs to contact either the peptide or
the MHC, since all CDR – pMHC contacts are equally
considered.
We used a test set of 10 known crystal structures to assess the
efficiency of the ab initio CDR prediction method according to its
ability to reproduce CDR loop conformations and crystal contacts.
The accuracy of our approach was then compared to other
selection methods based on several popular scoring functions
(Anolea [14], Dope [15] and the Modeller scoring function [10]).
Ultimately, the modeling of 6 TCRpMHC structures from
experimental sequences related to the NY-ESO-1 TCR repertoire
revealed a striking mechanism of selection through the presence of
a single conserved Gly situated in the center of all CDR3b.A nin
vitro experimental functional study of mutations of this amino acid
combined with in silico modeling of several mutants was
performed. It confirmed that dramatic predicted structural
changes caused by these mutation are linked to the loss of affinity
of the TCR to NY-ESO-1/HLA-A*0201.
Results
Figure 1 shows the detailed modeling procedure. In the
following, Root Mean Square Deviations (RMSD) are calculated
over heavy atoms, unless specified otherwise.
CDR loops prediction
We first assessed the capacity of the ab initio prediction (Figure 1)
to model a single CDR loop in its crystallographic environment,
bound to pMHC. This approach is referred to as the single-loop
approach. Each CDR loop from 10 available TCRpMHC crystal
structures was modeled (see Table 1) using the ab initio prediction
and the crystal structure as the initial loop conformation. A total of
60 CDR loops of different lengths were computed (CDR1 length:
8 to 10 amino acids, CDR2: 5 to 7 and CDR3: 3 to 11). 82% of
the predicted CDR had a RMSD from the crystal structure below
the 3.0 A ˚ threshold used to define successful predictions (see
Discussion). The average RMSD was 2.21 A ˚ (Table 1). Hence,
single CDR were successfully predicted in the environment
provided by the crystal structure. During this test, we verified
that the sampling (see Methods) was not confined in the starting
local minimum and artificially biased towards the reference
structure, i.e. that no memory effect exists. For this, we computed
the RMSD between the starting structure and the first CDR
conformer for each CDR. An average of 3.70 A ˚ (SD=1.68) was
obtained, which confirmed that the exploration of the conforma-
tional space was effective from the beginning of the simulation.
Two CDR3 loops showed a RMSD to crystal above 5 A ˚: 1fo0
CDR3a with 5.95 A ˚ and 1nam CDR3b with 6.21 A ˚. Interesting-
ly, the structural analysis of the 1fo0 crystal demonstrated that a
hydrogen bond is present between the hydroxyl group of the
Tyr97 residue of CDR3a and the backbone carbonyl of Ala135 of
a neighbor MHC molecule in the crystal. This crystal contact
apparently deviates the CDR3 away from the pMHC in the
experimental structure. When 1fo0 CDR3a loop is modeled
without the crystal environment, it adopts a conformation directed
towards the peptide as a direct consequence of the use of iterative
hydrogen bonds restraints during the simulated annealing
procedure (see Methods and Figure S1). 1fo0 was hence not
considered further in this study. Figure 2 shows successful
predictions for six illustrative loops computed in the single-loop
approach, both in terms of RMSD from the experimental
structure and hydrogen bonds reproduction.
We tested the ability of the ab initio prediction to model all 6
CDR of each TCR crystal in a successive-loops approach, a
scenario corresponding to the real application (Figure 1). The
CDR were modeled in the following order: CDR2b, CDR1b,
CDR2a, CDR1a and finally both CDR3 together. The choice of
this sequence was devised to model first the CDR in the periphery
of the TCR binding site, since they generally do not play the key
role in TCR-peptide recognition, as opposed to CDR3 loops [16].
Once the CDR2b has been predicted, its conformation is kept
fixed during the subsequent optimization of CDR1b and so on
with the other CDR in the order mentioned above. This
successive-loops approach showed a success rate of 72% compared
to 82% for the single-loops scenario (see Table 1). The average
RMSD from the crystal structures was 2.48 A ˚ (SD=1.32)
compared to 2.21 A ˚ (SD=1.12) for the single-loop approach.
Interestingly, we reported that an incorrectly predicted CDR loop
did not systematically lead to a failure for the modeling of
subsequent loops. Indeed, the RMSD for 1mi5 CDR1a and b
were 2.81 A ˚ and 1.46 A ˚, respectively, while the RMSD for the
CDR2a and b modeled in the previous step were 3.49 A ˚ and
4.81 A ˚, respectively (Table 1). This illustrates the robustness of the
algorithm with respect to the accuracy of the loop environment.
Numerical data for all loops computed both by single-loop and
successive-loop approaches are given in Table 1 and Table 2.
At the sequence level, very few CDR properties could help
predict the success or the failure of our structure prediction
algorithm. Nevertheless, CDR length is a useful indicator
(Figure 3A). As could be observed, RMSD values between
predictions and their respective crystal references slightly increased
in average, with the loop length. A n/DN-C score was defined as the
ratio between the number of residues that form the loop, n, and
the distance between the N-terminal and C-terminal ends of the
CDR, DN-C. This score describes the «elongation» of the
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elongated loops, and large values to curved ones. It reflects the size
of the accessible conformational space for a loop of a given
number of residues, which is expected to be larger for curved
loops. Considering our 3.0 A ˚ success criteria for RMSD (see
Discussion), Figure 3B shows that a CDR loop is likely to be
correctly predicted ab initio when its n/DN-C is lower than 0.9 A ˚ 21.
The 0.9 cutoff still retained 50% of the cases present in the test set,
whereas the cutoff based on the number of residues alone (loops
that are no longer than 6 residues are correctly predicted) retained
less than 30% (Figure 3A). Despite its limitations, the n/DN-C is
thus a better descriptor than n alone, to identify the cases likely to
be correctly predicted. For larger values of n/DN-C, the quality and
the reliability of the prediction cannot be assessed a priori.
Potential hydrogen bonds identification
The biological function of a TCR depends on its affinity for the
peptide-MHC complex [17,18] [19]. This affinity is, in turn, a
function of the interactions taking place at the TCRpMHC
interface, and in particular of the hydrogen bonds [13]. Therefore,
Figure 1. TCRpMHC modeling general procedure. Key steps are numbered in black boxes and referenced to in the Materials and Methods
section.
doi:10.1371/journal.pone.0026301.g001
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restrain the exploration of the conformational space to regions of
high occurrence of hydrogen bonds between the TCR and the
pMHC (see Methods).
An analysis of the structures of CDR predicted by the single-
loop and successive-loops modeling approaches showed that the
final models reproduced 77% and 52% of the total 66 hydrogen
bonds present in the crystal structures, respectively (Table 2). The
performance of TCRep 3D in hydrogen bonds reproduction is in
reasonable qualitative agreement with the RMSD from the
experimental structure. Indeed, among the loops that were
predicted with a RMSD lower than 3.0 A ˚ from the experimental
structure, 83% and 59% of the potential hydrogen bonds were
reproduced by the single and successive CDR modeling,
respectively (see Table 1 and Table 2).
Interestingly, the approach performed differently on loops with no
hydrogen bond in the crystal. Indeed, all the CDR with no hydrogen
bond withthepMHCin thereferencecrystalshowed onaverage 1.33
(SD=1.33) potential hydrogen bonds identified in the successive-
loops approach. This number was significantly higher for the CDR
loops showing hydrogen bounds in the crystal structure: 2.70
(SD=1.57, p,0.001). An average of 13.2 potential hydrogen bonds
(SD=10.8) were identified during the sampling of a given CDR loop
in the last iteration (see methods). It is noteworthy however that 78%
of the hydrogen bonds present in the crystal were actually observed
among the 6 most frequent ones sampled on each CDR.
Iterative sampling and scoring quality
The important novel aspects of TCRep 3D are the systematic
use of canonical restraints and hydrogen bonds derived restraints
Table 1. RMSD, in A ˚, calculated for each CDR of the test set of 10 crystal structures, for independent and sequential ab initio loop
modeling.
Model vs crystal root mean square deviation [A ˚]
PDB ID CDR2b CDR1b CDR2a CDR1a CDR3a CDR3b Average (SD)
1ao7 Number of residues 78598 9
Independent loops modeling 0.66 1.62 1.88 2.27 1.72 2.42 1.76 (0.62)
Sequential loops modeling 0.66 1.60 1.88 3.37 1.94 2.74 2.03 (0.94)
1bd2 78696 8
" 0.56 2.93 1.43 2.54 2.77 2.89 2.19 (0.97)
2.29 1.64 1.61 2.78 1.26 3.65 2.21 (0.89)
1g6r 78696 8
" 1.44 1.51 1.41 1.96 0.93 1.36 1.44 (0.33)
1.44 1.62 1.40 2.57 0.89 3.80 1.95 (1.06)
1kj2 79697 1 1
" 1.19 3.98 1.11 1.61 1.14 4.11 2.19 (1.45)
1.28 4.07 1.68 2.32 3.50 6.04 3.15 (1.77)
1lp9 78599 5
" 1.26 1.42 1.96 2.28 1.26 2.62 1.80 (0.58)
1.26 1.73 2.19 2.80 1.48 4.39 2.31 (1.16)
1mi5 7861 0 1 0 6
" 4.79 2.29 1.55 2.61 4.45 1.58 2.88 (1.41)
4.81 1.46 3.49 2.81 5.64 2.02 3.37 (1.61)
1nam 7971 0 1 0 7
" 3.00 4.54 2.62 3.22 2.80 6.21 3.73 (1.39)
3.09 4.66 1.54 4.41 2.74 6.38 3.80 (1.7)
1oga 78687 5
" 1.15 1.86 2.66 0.93 3.83 1.14 1.93 (1.13)
1.24 1.86 2.61 0.95 3.80 1.24 1.95 (1.08)
2ckb 78696 3
" 1.56 1.78 2.54 3.09 1.41 1.37 1.96 (0.7)
1.29 1.23 2.21 2.20 1.13 1.76 1.64 (0.49)
2bnr 78699 7
" 1.12 1.86 2.80 2.24 2.16 3.35 2.26 (0.77)
1.24 1.40 2.53 3.09 3.64 2.65 2.43 (0.94)
Average 7.0 (0) 8.2 (0.4) 5.9 (0.54) 9.1 (0.54) 7.8 (1.54) 6.9 (2.17)
(SD) " 1.67 (1.22) 2.38 (1.03) 2.00 (0.59) 2.28 (0.64) 2.25 (1.13) 2.71 (1.49) 2.21 (1.12)
1.86 (1.18) 2.13 (1.14) 2.11 (0.61) 2.73 (0.84) 2.60 (1.45) 3.47 (1.65) 2.48 (1.32)
doi:10.1371/journal.pone.0026301.t001
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based on the sampled hydrogen bonds (see Materials and
Methods). The efficiency of the ab initio prediction to produce an
optimal model was compared to standard approaches and our
scoring function was compared to several well established energy
scoring methods: Anolea [14], Dope [15] and the Modeller pseudo-
energy [10] scoring functions.
Starting from the crystal structures, the CDR were indepen-
dently modeled without adding restraints and a standard set of
2000 conformers with a Modeller pseudo-energy function value
lower than 500 was collected for each CDR loop. The energy of
each conformer was then computed, using the Anolea, Dope and
the Modeller scoring functions. For each scoring function, we
selected the conformer with the lowest energy as a final model.
The average RMSD of the 60 single loops selected among a set of
2000 structures generated were computed for each function
(Figure 4A). The average RMSD values were respectively 3.64 A ˚
(SD=1.57), 3.05 A ˚ (SD=1.57) and 3.09 A ˚ (SD=1.76). The use
of these scoring functions after the iterative H-bonds sampling as
implemented in TCRep 3D improved the average RMSD (2.52 A ˚
(SD=1.43), 2.47 A ˚ (SD=1.60) and 2.31 A ˚ (SD=1.75), respec-
tively), in comparison to TCRep 3D which produced the best
average RMSD value at 2.21 A ˚ (SD=1.12). Interestingly, our
iterative sampling algorithm brought the average RMSD below
the 3.0 A ˚ cutoff irrespective of the scoring function. TCRep 3D
performed significantly better than unrestrained simulated an-
nealing with Anolea, Dope or Modeller scoring functions
(p,0.001, p,0.005, p,0.0001, respectively). We identified for
each loop, the element in the set of 2000 conformers with the
lowest RMSD from the crystal; the corresponding RMSD average
value over the 60 CDR was 1.24 A ˚ (SD=0.43) for the standard set
and 1.23 A ˚ (SD=0.66) for the iterative set (i.e. modeled with
restraints, see Methods).
Since the longest CDR loops, and also the most important loop
modeling failures were contained in the CDR3 set (see Table 1),
the same analysis restricted to CDR3 only was performed. It
showed slightly higher average RMSD with Anolea, Dope or
Modeller (4.07 A ˚ (SD=2.14), 3.68 A ˚ (SD=1.88) and 2.88 A ˚
(SD=2.17), respectively) (Figure 4B). Results improved after
hydrogen bonds iterative sampling, with average RMSD of 3.36 A ˚
(SD=1.92), 3.59 A ˚ (SD=2.31) and 2.79 A ˚ (SD=2.81) respec-
tively. Again, with an average RMSD of 2.48 A ˚ (SD=1.38), our
algorithm remained below the 3.0 A ˚ threshold with better
performance (p,0.399, p,0.066, p,0.021 respectively). The
average RMSD in the standard and iterative sets were 1.26 A ˚
(SD=0.44) and 1.34 A ˚ (SD=0.66), respectively, for the lowest
RMSD selection restricted to CDR3. In summary, these results
showed that TCRep 3D outperforms significantly standard
methods in producing relevant loops conformations.
A key Gly on CDR3b of NY-ESO-1 specific TCR
NY-ESO-1157–165 is one of the most important tumor antigen in
melanoma [20] and is currently being used in many clinical trials.
Analysis of the TCR repertoire selected in these patients has
provided us with a large number of sequence data for which
structural interpretation is needed [7]. These sequences were
identified from naturally occurring HLA-A*0201/NY-ESO-
1157–165–specific CD8+ T cells from five melanoma patients.
Among them, LAU 155#1 TCR has a sequence identical to
that of the experimental structure Va23-Vb13 TCR bound to NY-
Figure 2. A selection of CDR structures successfully modeled by the single-loop approach in the ab initio prediction. Experimental
structures (purple) are superimposed to CDR models (cyan). Oxygen, nitrogen and sulfur atoms are colored in red, blue and yellow, respectively.
Dotted lines show hydrogen bonds between CDR and pMHC. Hydrogen bonds reproduced by the model in green and in orange otherwise. In the
case of 1lp9 CDR3, the hydrogen bond with pMHC which is not reproduced (involving Ala97), is replaced in the model by another hydrogen bond
involving the carbonyl group of the Ser98 backbone (additional contact in Table 2).
doi:10.1371/journal.pone.0026301.g002
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situated on the CDR3a (Gln95, Thr96, Ala97 instead of Thr95,
Ser96, Asn97) and CDR3b (Ala97, Ala98 instead of Asn97, Thr98).
In total, 6 TCR sequences showed a TCRVb13 gene usage (CDR3
sequences and encoding gene numbers are shown in Figure 5A).
Considering this, we focused on them and used the procedure
described by Michielin et. al. [9] to build homology models of our
target sequences using the 2bnr TCRpMHC complex along with
TCR structures of our data set (see Methods and Table S1) as
templates. This constrained the TCR binding orientation over the
pMHC according to the known specific diagonal binding mode of
Va23-Vb13 TCR bound to NY-ESO-1 [22]. As a consequence,
very small structural deviations were observed between the pMHC
in the models and the structure of 2bnr. The largest calculated
RMSD between one of our models and the pMHC crystal structure
was 1.19 A ˚. In particular, although the structure of the peptide
showed small variations, especially on side chains (see Figure 5B), its
overall position in the model was very close to that in the crystal
structure, with a RMSD lower than 1.0 A ˚ after superposition of the
pMHC. We then appliedour TCRep3D successive-loopsmodeling
algorithm to the homology-derived models to obtain a detailed
analysis of TCR-pMHC interactions within this subset of the NY-
ESO-1 TCR repertoire.
All final models reproduced the binding motif of CDR3 a and b
making a lock around the two central residues Met4 and Trp5 of
the peptide as described by Sami et al. [22] [7]. A structural
alignment of the six models was performed and revealed a
conserved central position for a Gly residue in the CDR3b
sequence (Figure 5A, the central Gly is slightly shifted for LAU
50#1). Indeed, this Gly is remarkably conserved in all six CDR3b
sequences and was shown to fit structurally into a notch under the
peptide Trp5 side chain (Figure 5B).
Table 2. Hydrogen bonds statistics in the test set for independent and sequential ab initio loop modeling.
Hydrogen bonds between TCR and pMHC : reproduced/total (additionnal)
PDB ID CDR2b CDR1b CDR2a CDR1a CDR3a CDR3b Total
1ao7 Number of residues 7859 89
Independent loops modeling 0/0 (0) 1/1 (0) 0/0 (1) 1/2 (2) 5/5 (1) 2/3 (1) 9/11 (5)
Sequential loops modeling 0/0 (0) 1/1 (0) 0/0 (1) 0/2 (4) 1/5 (1) 0/3 (0) 2/11 (6)
1bd2 7869 68
" 0/0 (0) 0/0 (3) 1/1 (0) 1/1 (1) 2/3 (1) 0/1 (1) 4/6 (6)
0/0 (0) 0/0 (1) 1/1 (0) 1/1 (0) 2/3 (2) 0/1 (2) 4/6 (5)
1g6r 7869 68
" 0/0 (1) 1/1 (3) 0/0 (2) 0/2 (1) 2/2 (1) 0/0 (1) 3/5 (9)
0/0 (1) 0/1 (3) 0/0 (2) 0/2 (2) 2/2 (0) 0/0 (1) 2/5 (9)
1kj2 7969 71 1
" 2/2 (1) 0/0 (4) 0/0 (0) 1/1 (1) 3/3 (1) 1/1 (6) 7/7 (13)
2/2 (1) 0/0 (4) 0/0 (2) 1/1 (1) 2/3 (2) 0/1 (5) 5/7 (15)
1lp9 7859 95
" 0/0 (0) 1/1 (0) 0/0 (1) 0/0 (1) 3/4 (4) 0/0 (1) 4/5 (7)
0/0 (0) 1/1 (0) 0/0 (2) 0/0 (1) 2/4 (4) 0/0 (0) 3/5 (7)
1mi5 7861 0 1 0 6
" 2/2 (3) 0/0 (0) 0/0 (1) 2/2 (0) 0/1 (5) 3/4 (2) 7/9 (11)
2/2 (2) 0/0 (0) 0/0 (2) 1/2 (1) 0/1 (6) 1/4 (3) 4/9 (14)
1nam 7971 0 1 0 7
" 0/0 (2) 0/0 (2) 0/0 (1) 0/1 (4) 1/2 (1) 0/0 (3) 1/3 (13)
0/0 (1) 0/0 (2) 0/0 (1) 0/1 (2) 1/2 (2) 0/0 (1) 1/3 (9)
1oga 7868 75
" 2/2 (0) 1/1 (0) 0/0 (0) 0/0 (0) 0/0 (5) 4/4 (2) 7/7 (7)
2/2 (0) 1/1 (0) 0/0 (0) 0/0 (0) 0/0 (5) 2/4 (1) 5/7 (6)
2ckb 7869 63
" 0/0 (2) 0/0 (4) 0/0 (2) 1/2 (3) 1/2 (2) 0/0 (1) 2/4 (14)
0/0 (3) 0/0 (3) 0/0 (2) 2/2 (3) 1/2 (2) 0/0 (0) 3/4 (13)
2bnr 7869 97
" 1/1 (0) 1/1 (0) 1/1 (1) 0/0 (0) 2/4 (2) 2/2 (4) 7/9 (7)
1/1 (0) 1/1 (0) 1/1 (1) 0/0 (2) 0/4 (1) 2/2 (3) 5/9 (7)
Total ---- --
" 7/7 (9) 5/5 (16) 2/2 (8) 6/11 (13) 19/26 (23) 12/15 (22) 51/66 (92)
7/7 (8) 4/5 (13) 2/2 (13) 5/11 (16) 11/26 (25) 5/15 (16) 34/66 (91)
doi:10.1371/journal.pone.0026301.t002
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Gly to Ala and Ser. We repeated the coupled CDR3 a and b ab
initio modeling on the six models. Modeling results showed a
dramatic conformational change of the CDR3b. For example, the
RMSD from the wild type CDR3b, calculated for the backbone
atoms, were 5.88 A ˚ (Gly to Ala) and 3.28 A ˚ (Gly to Ser) for LAU
155#1 CDR3b (Figure 6A). This was confirmed on all the six
mutated structures, for both Ala and Ser mutations with backbone
RMSD values ranging from 3.09 A ˚ to 5.88 A ˚. All mutated loops
were unable to fit into the peptide notch.
Experimental mutations of the LAU 155#1 TCR Gly96
confirmed the importance of this central Gly in the CDR3b
sequence in vitro. Soluble wild type and Gly96 to Ser mutant TCR,
and NY-ESO-1/HLA-A*0201 pMHC were produced. Figure 6B
shows the dramatic loss of binding affinity for the Gly96 to Ser
mutant measured by titration ELISA experiment. Additionally,
Gly96 to Ala mutated TCR was expressed at the surface of the T-
cell line SUP-T1 using lentiviral vectors, and binding of NY-ESO-
1/pMHC multimer, as measured by flow cytometry, was also
completely lost (see Figure 6C).
Discussion
There is a considerable interest amongst immunology groups
studying T-cell biology to obtain functional information from
TCR repertoire sequences. We set up an automated and dedicated
system to model TCRpMHC complexes, focused on modeling the
interface of the complex, especially hypervariable CDR loops.
Clearly, only simulations of TCR bound to pMHC were
performed in order to identify binding motifs governing the
definition of TCR repertoires. The method presented in this paper
showed a high efficiency and robustness for the prediction of
TCRpMHC interfaces. Our method relies on using canonical
group knowledge for CDR1 and CDR2 loops, successively
refining CDR loops, iteratively looking for hydrogen bonds at
TCR - pMHC interface and clustering simulated annealing
models to select the best TCRpMHC model. Identifying CDR
interactions with pMHC is key to understand the mechanisms of
TCR selection while the models generated may provide optimal
initial conditions for further TCR engineering [23].
Canonical restraints and sampling quality
We expanded the canonical restraints on backbone dihedral
angles described by Al-lazikani et al. [5] with new crystallographic
data (Table S2). Canonical restraints were defined by their average
values and standard deviations (SD). The restraint violation
computed by Modeller depends crucially on the SD value [10]; the
smaller the SD, the larger the violation. The efficiency of such
dihedral angles restrictions was confirmed in ab initio simulations.
As an example, Figure S2 shows the Ramachandran plots of the
Arg residue at position 2 of CDR2b of 1kj2, for both unrestrained
and restrained simulations. Restraints of Al-lazikani group b2-2
were used, i.e. Q=2106.71u with SD=24.97u and y=44.97u
with SD=97.68u. As expected, the Q and y angles sampled in the
restrained simulation correspond to those defined by the canonical
restraints (i.e. 2160u#Q#270u and 2180u#y#180u). It is
noteworthy that the large SD of y values in the canonical
restraint implies that all y values can be sampled, as it was actually
observed, while the Q angle is effectively restricted, according to
the corresponding SD. In the region of the Ramachandran plot
defined by the restraints, the sampling performed in the restrained
simulation is comparable to that of the unrestrained one; the entire
allowed region is well sampled. This confirms that the loops were
not confined in a few narrow local energy minima during the
production of conformers with canonical restraints. The applica-
tion of restraints on the accessible conformational space of the
CDR also successfully prevented the system to reach energetically
unfavorable conformations and restricted simulations to more
relevant regions of space (data not shown). Technically, this
Figure 3. RMSD of all predicted single-loops of the test set plotted against two parameters. (A) RMSD against the number of residues n
that form the loop, (B) RMSD against the n/DN-C value of the loop in A ˚21. The ratio n/DN-C, is a good a priori indicator of modeling success.
doi:10.1371/journal.pone.0026301.g003
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time required to collect 2000 CDR conformers with a Modeller
pseudo-energy function below a cutoff of 500 (see methods) was
divided by (up to) 3 when canonical restraints were available.
RMSD cutoff
For the evaluation of loop modeling successes, we used an
empiric heavy atom RMSD cutoff of 3.0 A ˚. The structure
similarity between predictions and experimental conformations,
i.e. reproduction of the global conformation and native contacts,
was satisfying according to systematic visual inspections of all
superimposed structures (see results and Figure 2). To test the
influence of the RMSD cutoff value on the success rate (see
results), a 3.5 A ˚ cutoff was considered, for which the success rates
were 88% for single-loops and 82% for successive-loops proce-
dures compared to 82% and 72%, respectively, for the 3.0 A
cutoff. Nevertheless, for cases corresponding to RMSD between
3A ˚ and 3.5 A ˚, the quality of the prediction was not satisfying for
all CDR: in some cases, the method was not able to reproduce the
experimental hydrogen bonds, but created alternative ones, while
the conformation was strongly altered compared to the crystal
structure, see below, Table 1, Table 2 and Figure 7. Although
1nam CDR1a and 2bnr CDR3b have heavy atoms RMSD values
of 3.22 A ˚ and 3.35 A ˚, respectively, the prediction could be
considered a success in the second case, but not in the first one,
showing that a 3.5 A ˚ cutoff does not separate properly successes
and failures. As a consequence, the more stringent RMSD cutoff
of 3.0 A ˚ was used in this study.
Intensive hydrogen bonds search
Because the creation of hydrogen bonds between CDR loops
and MHC is an important mechanism that governs the selection of
a TCR repertoire [13], our approach incorporated a novel
iterative strategy to converge towards such favorable interaction
pattern between TCR and pMHC. The efficiency of the hydrogen
bonds sampling generally increased through the application of
hydrogen bonds derived restraints, compared to a modeling
without iterations (data not shown).
As an illustration, the impact of this strategy on the modeling of
1kj2 CDR3a, a difficult loop to model (n/DN-C=1.1 A ˚ 21), is
presented in Figure 8. On average, the RMSD of the conformers
decreased from 5.31 A ˚ (SD=1.68) initially to 3.61 A ˚ (SD=1.34)
after three iteration steps. In the complete set of 2000 conformers,
the total number of sampled hydrogen bonds and the proportion
of hydrogen bonds present in the reference crystal increased. After
three iterations, the final conformer had 2 out of the 3 hydrogen
bonds present in the reference structure, while its RMSD initially
at 5.66 A ˚ reached 3.23 A ˚. Increasing the number of iterations to 4
Figure 4. TCRep 3D performs better than common modeling approaches because of iterative hydrogen bonds sampling. Single-loop
test set modeling with Anolea, Dope or Modeller pseudo-energy scoring functions with and without iterative hydrogen bond sampling compared to
TCRep 3D. (A) All-loops average RMSD of models to crystal structures. (B) CDR3 loops average RMSD. (*: p-value,0.05, **: p-value,0.01).
doi:10.1371/journal.pone.0026301.g004
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bonds. For the general approach, 3 iterations were made, since this
provided the best compromise between modeling improvement
and required CPU time (data not shown).
This approach led to the identification of numerous potential
hydrogen bond contacts, with many not observed in the crystal
structures. Obviously, the crystal structure of a TCRpMHC
provides an average conformation of the molecules in the crystal
state and does not describes comprehensively its dynamical
behavior at room temperature in solution.
Successive-loops modeling
The single-loops approach was set up to assess our ability to
model a loop in the correct environment provided by the known
crystal structure. The method gave a satisfying success rate of
82% using the 3.0 A ˚ cutoff discussed earlier, illustrating the
efficiency of the loop modeling procedure when the environment
of the modeled part is correct. The success rate decreased to 72%
for the successive-loops approach. The performance change can
be explained by the accumulation of errors during the successive
modeling of the loops; indeed errors during CDR2 modeling will
impact the CDR1 modeling, whose error will, in turn, impact the
CDR3 modeling. Successive-loops modeling of the CDR is
however required in the general case since a standard homology
modeling procedure cannot provide reliable structures for all
CDR as TCR templates are in limited number and CDR
conformations may differ from unbound to bound states [9] [22]
[24] [25]. It is worth noting that, in our approach, the
conformational space that is explored by CDR loops is much
larger than the amplitude of CDR conformational change upon
binding. And since there is no memory effect during the ab initio
modeling (see Results), our results are not influenced by the
amplitude of the conformational change of the CDRs upon
binding (Figure S3).
The CDR refinement starts from the periphery of the binding
site, to end with central CDR3. In this manner, the most reliable
environment can be predicted for the central CDR3 that interact
the most with the rest of the CDRs, and is also often responsible
for most of the interactions with the peptide. The choice of a
sequential approach, where loops are modeled individually was
dictated by the need to sample reasonably sized conformational
spaces [26].
Figure 5. Sequence and structural models of the experimental set of CDR3b specific to NY-ESO-1/HLA-A2. (A) TCRVb sequences of the
experimental set of TCR, and structural alignment of the CDR3b, based on our structure predictions allow the identification of a conserved central Gly
residue (conserved residues are colored). (B) Structural superposition of the peptide and the CDR3b of the six predicted TCR structures bound to NY-
ESO-1/HLA-A2 visually confirm the key position of the central Gly of each CDR3b (green) for the CDR lock conformation around the peptide’s Met4
and Trp5.
doi:10.1371/journal.pone.0026301.g005
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In non-successful cases, either CDR loops were unusually long
(11 residues for 1kj2 CDR3b) or the accessible conformational
space of the loop was particularly large. Indeed, for the most
notable failures, the n/DN-C values are 0.98, 1.28 and 1.22 A ˚ 21 for
1mi5 CDR3a, 1kj2 CDR3b and 1nam CDR3b, respectively (see
Table 1). As mentioned earlier, high values of n/DN-C are
associated with a larger conformational space to sample.
In these cases, the small number of hydrogen bonds made with
the pMHC in the crystal structure (0 or 1) also suggested that
CDR loop conformation is determined by other types of
interactions (mainly non polar) with the pMHC or interactions
within the TCR itself [27] [28].
NY-ESO-1 TCR repertoire structure prediction
Using our approach, we predicted six TCRpMHC structures of
specific TCR recognizing NY-ESO-1/HLA-A*0201. Previous
studies have already stated important characteristics of the
interaction between TCR and pMHC in this repertoire.
Experimental alanine scanning and in silico binding free energy
calculations pointed out the importance of the central Met4/Trp5
residues of the NY-ESO-1 peptide in the recognition by TCR
bearing the BV13 chain [7]. Also, Sami et al. [22] observed from
recently published crystal structures of one given TCR (pdb 2PYE
and 2PYF) that the CDR3b is subject to an important structural
rearrangement upon complexation to NY-ESO-1/HLA-A2 and
that CDR3a and b adopt a lock conformation around the peptide
Met4 and Trp5. Our models showed this lock conformation for all
the analyzed TCR of the repertoire. We further identified a
conserved central Gly residue in the CDR3b sequence fitting into
the notch formed by the Trp5 (Figure 5) and playing a key role in
this lock conformation. Indeed, dramatic structural rearrangements
were observed upon in silico mutations of the Gly to small residues
Ala and Ser, which suggested that the proper lock conformation of
the CDR3a and b was not accessible anymore. Experimental
titration ELISA of soluble TCR and pMHC as well as
measurements by flow cytometry of multimer binding at the
surface of T-cells of the Ala and Ser mutants actually showed a
total loss of binding affinity of the TCR to NY-ESO-1/HLA-A2
(Figure 6), which may be explained by the particular role played
by the Gly residue in our model.
Possible explanations for the structural rearrangement and the
loss of affinity upon complexation include: (i) the available space in
the notch formed by Trp5 is not sufficient to accept any side chain,
thus preventing the lock conformation of the CDR3 to occur. (ii)
the Gly residue may provide improved backbone flexibility to the
CDR3, as discussed by McCormack et al. [29] and Huang et al.
[30], because of the wider range of accessible combinations of Q
and y angles to Gly relative to other residues. This might be the
key allowing the CDR3 to structurally rearrange upon complex-
ation. Preliminary modeling results confirmed that the restriction
of the Gly Q and y angles to values accessible to other amino acids
prevented the CDR3 loop to adopt the lock conformation, and
resulted in structural deviations that were comparable to the ones
obtained by mutation to Ala and Ser (data not shown). The
flexibility of the loop may also allow its residues to have access to a
larger conformational space, in order to make optimal native
contacts with the environment.
In conclusion, the study of NY-ESO-1 binders with our
approach led to the rapid identification of key information that
was not evident at the sequence level. The agreement between
experiment and in silico results illustrates the efficiency of our
method for TCR repertoire analysis in identifying key structural
aspects linked to function, paving the road to structure-activity
relationships studies and rational TCR design.
Figure 7. Adequacy of 3.0 A ˚ RMSD cutoff. Structural and hydrogen bond inspection confirm the modeling failure of 1nam CDR1a, RMSD 3.22 A ˚,
while 2bnr CDR3b, RMSD 3.35 A ˚, may be considered a successful prediction. Structural superposition of predicted loops (cyan ribbon) for 1nam
CDR1a (A) and 2bnr CDR3b (B) with their respective crystal references (purple ribbon). Dotted lines: CDR-pMHC potential hydrogen bonds made
between the CDR and the pMHC, green: potential hydrogen bonds reproduced by the predicted loop, orange: potential hydrogen bonds observed in
the crystal structure but not in the prediction and black: additional potential hydrogen bonds of the modeled CDR. pMHC residues making hydrogen
bonds with the CDR are explicitly shown in ball and stick. Peptide and MHC are shown in ribbon representation, in transparent grey.
doi:10.1371/journal.pone.0026301.g007
Figure 6. In silico and experimental mutation results in NY-ESO-1 repertoire. Mutations confirm the importance of the central Gly in CDR3b.
(A) Dramatic structural rearrangements of predicted structures of mutated Gly96Ala (orange) and Gly96Ser (red) loops superposed with the non-
mutated predicted structure of the CDR3b of LAU 155#1 (cyan). (B) Duplicated experimental titration ELISA on LAU 155#1 TCR and Gly96Ser mutant
shows the loss of affinity resulting from these mutations. (C) Mutation of the Gly96 to Ala in CDR3b induced loss of binding of NY-ESO-1 multimer, as
seen at the surface of SupT1 cells transduced with lentiviral particles.
doi:10.1371/journal.pone.0026301.g006
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Two modules were used for the TCRpMHC structure
prediction from the amino acids sequence. First, the homology
module was used to build the overall TCRpMHC model, as
previously described by our group [9]. The ab initio prediction was
used next to refine the CDR loops that determine the TCR
specificity for a pMHC complex (Figure 1). Computations were
spread on a computing grid and minimal user input was required.
Manual setup
We defined a database of X-ray crystal structures available for
homology computations and for quality evaluation of the method
(Table S1). The peptide sequence to model was manually aligned
with the peptides of the library. The order in which CDR loops
were refined by the ab initio prediction was defined manually to
offer flexibility, with the option of simulating several CDR loops
simultaneously. All subsequent steps were automatically executed.
Automated workflow
The IMGTH [31] (IMGTH, the international ImMunoGeneT-
ics information systemH http://www.imgt.org) database provides
the positions of the two first complementary regions (CDR1 and
CDR2) for each TCR alleles. The method performed a one-by-
one alignment of the V chains of the target with the alleles
provided by IMGTH to match the target sequence with its
corresponding allele and determine the position of the CDR1 and
CDR2 in the target. The templates were structurally aligned
together and the target sequence was then aligned to the fixed
structural alignment to determine the position of the CDR3. CDR
loops have by definition limited sequence homology between
different TCR, and have thus to be modeled ab initio. Therefore,
canonical restraints on the Q and y dihedral angles of CDR loops
(mean value and standard deviation) were added to limit the
conformational space accessible to a CDR loop during the
modeling steps. Canonical restraints consider key residues in the
TCR sequence together with CDR length to categorize CDR in
canonical groups associated with dihedral angles values [5]. We
expanded the table available in the literature with more recent
crystallography data from TCR and TCRpMHC [8] (Table S2).
Homology modeling. When required (NY-ESO-1 TCR
repertoire analysis), the alignment defined above together with
the canonical restraints of CDR loops dihedral angles was used for
the homology modeling of the TCRpMHC complex. The
computation of homology models as well as the clustering
method were conducted as described by our group in [9]. The
whole TCRpMHC complex, including TCRVa, TCRVb,
peptide, MHC class I and b2-microglobuline, is built during this
step and is used then as an initial condition for CDR ab initio
modeling.
Figure 8. Iterative application of hydrogen bonds derived restrains improves simulation results. The example of 1kj2 CDR3a in
sequential loop modeling demonstrates for the complete set of 2000 conformers (A) increased number of hydrogen bonds sampled with larger
proportion of interactions present in the reference crystal and decreased mean RMSD at each iteration. (B) Statistics of the best conformers at each
iteration. Three iterations were sufficient to obtain optimal results.
doi:10.1371/journal.pone.0026301.g008
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refined successively according to the user-defined order. The first
CDR (or group of CDR) was modeled, using either a crystal
structure (assessment of the algorithm) or a homology structure
(NY-ESO-1 TCR repertoire analysis) as initial condition
(Figure 1.1). In this step, all the residues of the complex not
belonging to CDR loops remained fixed in space. Canonical
restraints were used as described above (Figure 1.2). The program
distributed the simulations on a computing grid until it collected
2000 conformers with a Modeller pseudo-energy function lower
than 500 (Figure 1.3). For each conformer of this set, potential
hydrogen bonds between the TCR and the pMHC were
identified. Then, 2000 new complexes were computed from the
same initial structure but with the potential hydrogen bonds
computed as additional restraints (Figure 1.4). Our aim was to bias
the population of conformers towards the region of conformational
space demonstrating TCR-antigen (i.e. pMHC) interaction. This
procedure was iterated 2 more times: on iteration i+1, the
hydrogen bonds occurring in at least 26i% of the 2000 conformers
were added as restraints to further restrict the conformation space
accessible to the system. (Figure 1.4). The RMSD matrix of the last
set of conformers allowed clustering the candidates (Figure 1.6 to
1.8) [9]. The RMSD cutoff of the algorithm was automatically
adjusted to ensure that the biggest cluster contained at least 20
conformers. To select the final conformer, the TCRep 3D scoring
function was computed for each conformer within the best mean
Modeller pseudo-energy cluster as the sum of the occurrence of
each of its potential hydrogen bonds between the TCR and the
pMHC in the 2000 conformers set (Figure 1.9). If no conformer in
that cluster made potential hydrogen bonds with the pMHC, the
one with the lowest pseudo-energy was selected. If another CDR (or
group of CDR) had to be modeled, this conformer was used as
initial condition. Therefore, to model one CDR, 8000 complete
TCRpMHC were generated and the clustering based on a
4006400 (or bigger) RMSD matrix was computed, leading to a
total computation time of about 7 CPU days on recent CPU
architecture. The parameters shown above for the iterative
modeling with canonical and hydrogen bonds restraints were set
to the maximal values allowing to obtain the results in a reasonable
amount of time, taking account of the available computing power.
Making 3 iterations after the first set of conformers was shown to
improve the ability of the ab initio prediction to model hydrogen
bonds accurately (see discussion and Figure 8).
Databases
TCR variable a and b chains CDR1 and CDR2 positions were
determined from IMGTH (http://www.imgt.org) [31]. In this
paper, crystallographic structures are named according to their
Protein Data Bank accession numbers (Research Collaboratory for
Structural Bioinformatics Protein Data Bank, http://www.rcsb.
org/pdb/) [12]. Crystal structures of TCRpMHC were selected
after the review of Rudolph et al. [8] : 1ao7 [32], 1bd2 [33], 1g6r
[34], 1kj2 [35], 1lp9 [36], 1mi5 [27], 1nam [28], 1oga [37], 2bnr
[21] and 2ckb [38] (Table S1). Redundant structures were ignored
in our test set, but they were used nonetheless for canonical groups
categorization. Crystal structures of TCR and fragments of TCR
were also included in the templates list for homology modeling and
canonical groups categorization: 1b88 [39], 1bec [40], 1i9e [41],
1h5b [42], 1kb5 [43], 1ktk [44], 1nfd [45] and 1934.4 (not in PDB)
[46].
Molecular modeling software
The automated approach to model the TCRpMHC complex
was programmed in Perl (http:www.perl.org) and simulations were
distributed on a computing grid. The following software was used
for specialized tasks. Sequence and alignments, homology and
CDR loop modeling were performed by Modeller 9v5 software
[10] (http://salilab.org/modeller/modeller.html), loop modeling
used the method of conjugated gradients combined with molecular
dynamics and simulated annealing [10,26]. Jali [47] performed
single sequences alignments with structurally aligned block of
crystal templates (http://bibiserv.techfak.uni-bielefeld.de/jali/).
Potential hydrogen bonds were identified with the HBplus
software version 3.15 [48].
Protein production and Titration ELISA
The alpha and beta chains of TCR LAU 155 (AV23.1 &
BV13.1), up to and including constant region residues alpha-
Cys209 and beta-Cys242, were cloned into pHYK8 under the
control of a CMV promoter. Similar to Chang et. al. [49], chain
pairing was facilitated with an acidic-basic zipper, and a His-tag
was included at the carboxy terminus of the beta chain. The
mutation beta-Gly96Ser was introduced using the QuickChangeH
mutagenesis kit (Stratagene, La Jola, CA). Soluble TCR was
produced at the Protein Expression Core Facility of the Ecole
Polytechnique Fe ´de ´rale de Lausanne in PEI transfected HEK 293
cells cultured over 5 days, and was subsequently purified with Ni-
NTA agarose (Qiagen, Valencia, CA) and imidazole elution.
Recombinant soluble HLA H and b2 microglobulin chains (HLA-
A2) were obtained using a prokaryotic expression system (pET;
R&D Systems, Minneapolis, MN) as previously described [50].
The chains were folded by dilution in the presence of NY-ESO-
1157–165 peptide (p) and subsequently purified by fast protein liquid
chromotography. The BirA enzymatic site, included at the
carboxy terminus of the H chain, was then biotinylated (Avidity,
Denver, CO). Protein quality was assessed by SDS-PAGE and
concentrations were determined by Bradford measurement.
Titration ELISA was used to assess TCR binding. Briefly,
biotinylated pHLA-A2 was captured in streptavidin-coated plate
wells blocked with 2% bovine serum albumin (BSA) in Tris
buffered saline (TBS, pH 7.4). Soluble TCR, titrated in TBS, 1%
BSA, 0.1% Tw, was incubated for 1.5 h at RT. TCR bound to the
pHLA-A2 was detected with anti-b chain TCR MAb (Pierce,
Rockford, IL; TCR1151) diluted 1/1500, followed by HRP-
conjugated-goat- (anti-mouse IgG)-Ab (Pierce, 31430), diluted 1/
1500 in TBS, 0.1% Tw, and HRP detection with ABTS in a citric
acid and phosphate solution containing H2O2. Plate wells were
thoroughly washed at each step. Plate readings were taken at
OD405–490 nm.
Lentiviral production, cell transduction and flow
cytometry analysis
The Gly96Ala substitution was introduced into the wild-type
(WT) TCR BV13.1 (patient LAU 155) DNA by PCR mutagenesis
using the QuickChange mutagenesis kit (Strategene, La Jolla, CA)
and confirmed by DNA sequencing (GenBank accession number:
JN180298). Lentiviral vectors were produced by transient
transfection of 293T cells, a human embryonic kidney (HEK)
epithelial cell line that expresses the SV40 large T antigen (ATCC)
[17], using a standard calcium phosphate precipitation protocol as
described elsewhere [17]. In brief, 293T cells were cotransfected
with the vector of interest (pRRL-hPGK-TCR Va23.1-IRES-
TCR Vb13.1) and the transfer vector, envelope, and packaging
plasmids (pRSV-Rev, pMD2-VSV-G, and pMDLg/pRRE).
Supernatants were harvested 24 h and 48 h post transfection,
filtered, and concentrated by ultracentrifugation. Pellets were
resuspended in sterile cold PBS and directly used. A total of
1610
6/ml of SUP-T1 cells were transferred to pretreated
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lentiviral supernatant. After 5 days of culture in RPMI 1640
(Invitrogen) supplemented with 10% fetal calf serum, 10 mM
Hepes, and antibiotics, cells were analyzed by flow cytometry
using PE-labeled HLA-A2/NY–ESO-1157–165 (SLLMWITQA)
multimer, FITC-conjugated antibody against human BV13.1 or
CD8-PE-Cy7.
Additional software
P-values were computed by the GraphPad Prism software.
Molecular representations were made using the Visual Molecular
Dynamics (VMD) software [51].
Supporting Information
Figure S1 (A) Crystal structure of 1fo0 CDR3a (red transpar-
ent), displayed with its crystal neighbor TCRpMHC complex. The
residues making the crystal contact, e.g. CDR3a Tyr97 (red) and
MHC Ala135 (green) are shown in sticks. (B) TCRep 3D model of
1fo0 CDR3a (red transparent) demonstrates a significant confor-
mational deviation from the crystal with a hydrogen bond between
CDR3a Tyr97 (red) and Asp4 of the peptide (green).
(EPS)
Figure S2 Ramachandran plot for 2000 conformers of 1kj2
CDR2b Arg50, in unrestrained simulations, and with canonical
restraints. The region defined by the canonical restraints is
localized by an orange line. Ramachandran positions of the
residues in the crystal structures are shown by an orange dot in
each plot. Colored surfaces correspond to the Q/y accessible areas
for all amino-acids except Gly. The plots are generated by the
VMD software.
(EPS)
Figure S3 Success of CDR loop modeling is independent of
conformational changes upon TCR binding to pMHC. RMSD of
all predicted single-loops of the test set plotted against the
corresponding RMSD between the bound and unbound crystal
structures [25] (when available).
(EPS)
Table S1 (A) List of TCRpMHC crystal structures used in the
test set. (B) List of crystal structures of unbound TCR and pMHC
used to complement the template list and update the definition of
canonical restraints.
(XLS)
Table S2 Table of the canonical groups defined by Al-Lazikani
et al. [5]. Angles and SD values were updated with more recent
structures (see Methods). Key residues are highlighted. The
canonical group a2-1 is entirely defined by residues that are
external to the CDR (e.g. Phe 32 and Leu 66).
(XLS)
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